AstraZeneca released two sets of phase III safety trial results for its Covid-19 vaccine, each showing slightly different efficacy rates. The inconsistency has kicked up controversy and confusion, but experts so far believe there is little impact on safety.Original Article
Controversy and confusion as AstraZeneca releases results
